{"id":9935,"date":"2019-09-13T06:50:40","date_gmt":"2019-09-13T10:50:40","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=9935"},"modified":"2019-09-13T06:50:40","modified_gmt":"2019-09-13T10:50:40","slug":"new-filings-updated-terms-ending-9-13-19am","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/new-filings-updated-terms-ending-9-13-19am\/","title":{"rendered":"New Filings &#038; Updated Terms (ending 9.13.19am)"},"content":{"rendered":"<p><!--more--><\/p>\n<p><span style=\"text-decoration: underline;\"><strong>NEW FILINGS<\/strong><\/span><br \/>\nCompany: BioNTech SE<br \/>\nSymbol: BNTX<br \/>\nDescription: BioNTech was founded in 2008 on the understanding that every cancer patient\u2019s tumor is unique and that in order to effectively address this challenge, we must create individualized treatments for each patient.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): JP Morgan, BofA Merrill Lynch, UBS Investment Bank, SVB Leerink<br \/>\nCo-Manager: Canaccord Genuity, Bryan Garnier &amp; Co., Berenberg, Wolfe Capital Markets, Kempen, Mirae Asset Securities<br \/>\nFiled: 9-4-19<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Frequency Therapeutics, Inc.<br \/>\nSymbol: FREQ<br \/>\nDescription: They are a clinical-stage biotechnology company focused on harnessing the body\u2019s innate biology to repair or reverse damage caused by a broad range of degenerative diseases.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): J.P. Morgan, Goldman Sachs, Cowen<br \/>\nCo-Manager: Mizuho Securities<br \/>\nFiled: 9-4-19<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: ADC Therapeutics SA<br \/>\nSymbol: ADCT<br \/>\nDescription: They are a clinical-stage oncology-focused biotechnology company pioneering the development of highly potent and targeted antibody drug conjugates for patients suffering from hematological malignancies and solid tumors.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Morgan Stanley, BofA Merrill Lynch, Cowen<br \/>\nFiled: 9-4-19<br \/>\nListed Cash Raise: $150m<\/p>\n<p>Company: Aprea Therapeutics Inc.<br \/>\nSymbol: APRE<br \/>\nDescription: They are a clinical-stage biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. p53 is the protein expressed from the TP53 gene, the most commonly mutated gene in cancer.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): JP Morgan, Morgan Stanley, RBC Capital<br \/>\nFiled: 9-4-19<br \/>\nListed Cash Raise: $86.25m<\/p>\n<p><span style=\"text-decoration: underline;\"><strong>TERMS ADDED<\/strong><\/span><br \/>\nCompany: Peloton Interactive, Inc.<br \/>\nSymbol: PTON<br \/>\nDescription: They are a technology company that meshes the physical and digital worlds to create a completely new, immersive, and connected fitness experience.<br \/>\nShares: 40.0 million<br \/>\nPrice Range: $26.00-$29.00<br \/>\nMarket Cap: $7.2b-$8.05b<br \/>\nTrade Date: Thursday, 9\/26<br \/>\nUnderwriter(s): Goldman Sachs, JP Morgan, BofA, Merrill Lynch, Barclays, UBS, Cowen<br \/>\nCo-Manager(s): Canaccord Genuity, Evercore ISI, JMP Securities, KeyBanc Capital Markets, Needham, Oppenheimer, Raymond James, Stifel, Suntrust Robinson Humphrey, William Blair, Telsey Advisory Group, Academy Securities, Siebert Cisneros Shank &amp; Co. LLC, R. Seelaus &amp; Co. LLC, The Williams Capital Group LP<br \/>\nTerms Added: 9-10-19<\/p>\n<p>Company: Exagen Inc.<br \/>\nSymbol: XGN<br \/>\nDescription: They are dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention.<br \/>\nShares: 3.33 million<br \/>\nPrice Range: $14.00-$16.00<br \/>\nMarket Cap: $157m-$180m<br \/>\nTrade Date: Thursday, 9\/19<br \/>\nUnderwriter(s): Cowen, Cantor, William Blair<br \/>\nTerms Added: 9-9-19<\/p>\n<p>Company: Datadog, Inc.<br \/>\nSymbol: DDOG<br \/>\nDescription: Datadog is the monitoring and analytics platform for developers, IT operations teams and business users in the cloud age.<br \/>\nShares: 24 million<br \/>\nPrice Range: $19.00-$22.00<br \/>\nMarket Cap: $5.5b-$6.4b<br \/>\nTrade Date: Thursday, 9\/19<br \/>\nUnderwriter(s): Morgan Stanley, Goldman Sachs, JP Morgan, Credit Suisse, Barclays, Jefferies, RBC Capital<br \/>\nCo-Manager(s): JMP Securities, Raymond James, Stifel, William Blair, Needham &amp; Co<br \/>\nTerms Added: 9-9-19<\/p>\n<p>Company: Ping Identity Holding Corp.<br \/>\nSymbol: PING<br \/>\nDescription: Ping is pioneering Intelligent Identity. They enable secure access to any service, application or API from any device.<br \/>\nShares: 12.5 million<br \/>\nPrice Range: $14.00-$16.00<br \/>\nMarket Cap: $1.1b-$1.25b<br \/>\nTrade Date: Thursday, 9\/19<br \/>\nUnderwriter(s): Goldman Sachs, BofA Merrill Lynch, RBC Capital, Citigroup, Barclays, Credit Suisse, Deutsche Bank, Wells Fargo<br \/>\nCo-Manager(s): Raymond James, Stifel, William Blair, Mizuho Securities, Oppenheimer<br \/>\nTerms Added: 9-9-19<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,1536],"tags":[],"class_list":["post-9935","post","type-post","status-publish","format-standard","hentry","category-ipo","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/9935","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=9935"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/9935\/revisions"}],"predecessor-version":[{"id":9936,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/9935\/revisions\/9936"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=9935"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=9935"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=9935"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}